Phreesia (NYSE:PHR) Shares Unloaded Rep. Josh Gottheimer

Key Points

• Rep. Josh Gottheimer sold between $1,001 and $15,000 of Phreesia (PHR) stock on March 5, a transaction disclosed on April 8 from his "MORGAN STANLEY - SELECT UMA ACCOUNT #1".
• Phreesia shares fell about 7.7% after reporting Q1 EPS of $0.02 versus a $0.07 consensus (revenue $127.07 million); insiders have sold roughly 40,367 shares in the last three months and analysts have trimmed targets (average target $22, rating: Moderate Buy).

Representative Josh Gottheimer (Democratic-New Jersey) recently sold shares of Phreesia, Inc. NYSE: PHR. In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Phreesia stock on March 5th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of ENN Energy OTCMKTS: XNGSY on 3/24/2026.
• Sold $1,001 - $15,000 in shares of Crown Castle NYSE: CCI on 3/24/2026.
• Purchased $1,001 - $15,000 in shares of Fabrinet NYSE: FN on 3/24/2026.
• Sold $1,001 - $15,000 in shares of Intapp NASDAQ: INTA on 3/12/2026.
• Sold $1,001 - $15,000 in shares of Alcon NYSE: ALC on 3/12/2026.
• Sold $1,001 - $15,000 in shares of La-Z-Boy NYSE: LZB on 3/12/2026.
• Sold $1,001 - $15,000 in shares of HDFC Bank NYSE: HDB on 3/12/2026.
• Sold $1,001 - $15,000 in shares of Infineon Technologies OTCMKTS: IFNNY on 3/12/2026.
• Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/10/2026.
• Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 3/6/2026.

Phreesia Stock Down 7.7%

Shares of PHR stock opened at $8.08 on Friday. The stock has a market cap of $490.94 million, a P/E ratio of 269.33 and a beta of 0.86. Phreesia, Inc. has a 52 week low of $7.77 and a 52 week high of $32.76. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. The company's fifty day simple moving average is $11.43 and its two-hundred day simple moving average is $16.92.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The company had revenue of $127.07 million during the quarter, compared to analysts' expectations of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The firm's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.11) EPS. Analysts predict that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling

In related news, General Counsel Allison C. Hoffman sold 6,176 shares of the stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $11.97, for a total value of $73,926.72. Following the sale, the general counsel directly owned 163,485 shares of the company's stock, valued at $1,956,915.45. This represents a 3.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Evan Roberts sold 6,268 shares of the stock in a transaction dated Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $102,544.48. Following the completion of the sale, the insider directly owned 826,554 shares in the company, valued at $13,522,423.44. This trade represents a 0.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 40,367 shares of company stock worth $613,251 over the last three months. 5.50% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have commented on PHR shares. Canaccord Genuity Group decreased their price target on shares of Phreesia from $33.00 to $22.00 and set a "buy" rating on the stock in a research note on Tuesday, March 31st. Weiss Ratings reiterated a "sell (e+)" rating on shares of Phreesia in a research note on Wednesday, January 28th. Zacks Research cut shares of Phreesia from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, January 6th. Wells Fargo & Company decreased their target price on shares of Phreesia from $30.00 to $25.00 and set an "overweight" rating on the stock in a research report on Thursday, March 26th. Finally, Needham & Company LLC decreased their target price on shares of Phreesia from $35.00 to $14.00 and set a "buy" rating on the stock in a research report on Tuesday, March 31st. Twelve research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Phreesia currently has an average rating of "Moderate Buy" and an average target price of $22.00.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Royal Bank of Canada raised its position in Phreesia by 208.8% in the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock worth $617,000 after purchasing an additional 16,309 shares during the period. AQR Capital Management LLC raised its position in Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock worth $4,090,000 after purchasing an additional 132,015 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after purchasing an additional 2,158 shares during the period. NewEdge Advisors LLC raised its position in Phreesia by 262.7% in the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after purchasing an additional 11,181 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in Phreesia by 0.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after purchasing an additional 2,402 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election. Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Phreesia Company Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.